Latest News
Investor Relations
Latest News
September 26, 2023 08:30 am
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
September 19, 2023 08:00 am
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
September 18, 2023 08:30 am
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
September 6, 2023 12:00 pm
BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell
March 23, 2023 07:30 am
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
March 7, 2023 07:30 am
BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.
February 14, 2023 08:55 am
BioStem Technologies Enters Into a Share Exchange Agreement
February 1, 2023 07:30 am
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
January 24, 2023 07:30 am
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
December 16, 2022 07:30 am